Ovarian Cancer | Tumor

CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.

Maintenance Zejula Induces Antitumor Activity, Increases Survival in Advanced Ovarian Cancer

June 7th 2023

Meaningful improvements in survival were obtained with Zejula maintenance therapy compared with placebo in patients with advanced ovarian cancer that was newly diagnosed.

Avastin Regimen Improves Survival in Ovarian Cancer, Including Some HRD-Positive Tumors

June 3rd 2023

A progression-free survival benefit was observed in patients with advanced ovarian cancer including those with homologous recombination deficient-positive status who were treated with frontline chemo plus Avastin and Imfinzi followed by maintenance therapy with an Avastin regimen.

Tumor Testing May Be Increasingly Useful in Ovarian Cancer

May 8th 2023

As more personalized treatments become available in the ovarian cancer space, tumor testing, such as next-generation sequencing, may play a bigger role.

Olympian Shares Her Cancer Experience: ‘Give Yourself Grace’

May 4th 2023

Olympic gymnast, Shannon Miller, sat down with CURE® to discuss her experience with a rare type of ovarian cancer, and how her competitive mindset helped her through.

Bucket-List Trip Provides Joyful ‘Cancer-Free’ Week

April 24th 2023

The best part of the trip was that I didn’t think about cancer. My husband and I didn’t talk about it for a whole week, and no one knew I had it.

Young, Healthy People Get Cancer Too

April 20th 2023

Before being diagnosed with stage 3 ovarian cancer at the age of 34, Jennifer Broxterman was constantly told that she was young and healthy — but the registered dietitian knew that something was off.

Novel HSF1 Pathway Inhibitor to Be Studied in Ovarian Carcinoma

April 10th 2023

A pharmaceutical company initiated a phase 1b study in patients with platinum-resistant, ARID1a-mutated ovarian carcinoma.

Elahere Symptoms Patients With Ovarian Cancer Should Look Out For

April 7th 2023

There are certain side effects from Elahere — a newly approved ovarian cancer drug — that patients taking the treatment should look out for, an expert said.

Social Media Can Connect Both Patients With Rare Cancers and Researchers

April 6th 2023

Social media, including Facebook groups, can help connect patients with rare cancers like granulosa cell tumors to researchers, allowing them to learn more about disease management.

Lynparza/Imfinzi Regimen Is ‘Encouraging’ for Advanced Ovarian Cancer

April 6th 2023

Interim findings from a clinical trial showed that adding Lynparza and Imfinzi to an Avastin and chemotherapy regimen tended to improve the time patients lived before their disease got worse.

Facing My Mortality from Cancer Made Me Grateful for Loved Ones

March 28th 2023

Twenty-five years ago, I was diagnosed with ovarian cancer, which sparked fears of leaving my loved ones behind.

Palliative Care Decreases Hospital Readmissions in Ovarian Cancer

March 27th 2023

Patients with ovarian cancer who utilized palliative care tended to have fewer hospital readmissions than those who did not, according to a recent study.

Strange Tattoos: A Look at My Cancer Experience

March 27th 2023

The temporary tattoos that guided the radiation for my cancer treatment were not beautiful, artistic or cool — they were more than that.

An Innovative Approach to Chemotherapy

March 13th 2023

Positive results have emerged from a trial testing PIPAC, a procedure used for appendiceal, ovarian, gastric and colon cancers that works by spraying chemotherapy directly onto tumors.

Novel Drug to Be Studied in Ovarian Cancer

February 10th 2023

After promising phase 1 results, ART0380 will be studied in a randomized phase 2 trial for patients with platinum-resistant ovarian cancer.

Anniversary Time: A Look Back of What I’ve Learned 10 Years After Cancer

February 1st 2023

I’m coming up on my 10-year cancer anniversary, and it feels bittersweet.

Ongoing Trial Shows Positive Response Rates With MEK Inhibitor Combo in Ovarian Cancer Subset

January 30th 2023

Women with low-grade serous ovarian cancer treated with avutometinib and defactinib experienced positive response rates compared with avutometinib alone.

First Patient Dosed with AVB-001 in Trial for Relapsed Refractory Ovarian Cancer

January 19th 2023

The trial is evaluating the safety and efficacy of AVB-001 patients with relapsed refractory ovarian cancer.

Beta-Blockers May Improve Post-Surgical Survival in Women With Ovarian Cancer, Heart Conditions

January 18th 2023

Women who were taking beta-blockers, a medicine to treat heart conditions like high blood pressure, among others, near the time of surgery for epithelial ovarian cancer may confer a survival benefit years after undergoing a procedure.

FDA Approval of Elahere Represents a ‘Step Forward’ for Platinum-Resistant Ovarian Cancer Subset

November 22nd 2022

One expert said that the FDA approval of the antibody-drug conjugate Elahere represents a new treatment option for patients with folate receptor alpha-positive, platinum resistant ovarian cancer.

I Shouldn’t Have to Pretend ‘Minor’ Side Effects From Cancer Treatment Don’t Bother Me

October 28th 2022

Researchers running clinical should be aware of how these new drugs affect our day-to-day lives — not just in the big ways, but also the small ones that take their toll over the long haul.

Lifestyle Changes and Non-Estrogen-Based Therapies May Alleviate Menopausal Symptoms in Women With Cancer

October 27th 2022

Women who face menopause after a cancer diagnosis may be able to manage their symptoms without relying on estrogen-based therapies, although discussing this with a cancer team will help patients find what’s best for them.

Standup Comedian and Self-Proclaimed 'Love Goddess' Judy Tenuta Dies From Cancer, New England Patriots Host a ‘Day of Pampering’ for Cancer Survivors and More

October 7th 2022

From the death of standup comedian and "Love Goddess" Judy Tenuta to professional sports hall-of-famers discussing their cancer, here’s what’s happening in the cancer space this week.

Early-Phase Trial to Study Novel Drug, With or Without Keytruda, in Solid Cancers

September 27th 2022

The novel drug PY159 will be studied as a single agent and in combination with Keytruda for patients with certain solid tumors — including ovarian, pancreatic, lung, head and neck, colorectal and breast cancers.

Phase 3 Trial to Study an Immunochemotherapy Regimen in Platinum-Resistant/Refractory Ovarian Cancer

September 26th 2022

The OnPrime trial will investigate if adding Olvi-Vec, a modified virus, to chemotherapy and Avastin will improve outcomes for pretreated platinum-resistant or refractory ovarian cancer.

Maintenance Therapy the 'Biggest Breakthrough in Decades' for Ovarian Cancer

September 15th 2022

Although maintenance treatments have helped patients with ovarian cancer live longer, experts note there are still some unmet needs that must be addressed.

CAR-T Cell Therapy Shows Promise in Relapsed/Refractory Solid Cancers

September 11th 2022

BNT211-01, a novel CAR-T cell therapy, was efficacious in treating patients with CLDN6-positive, relapsed/refractory solid cancers, according to a small clinical trial.

Rubraca Staves Off Disease Progression Better Than Chemotherapy in BRCA-Mutant Relapsed Ovarian Cancer, Research Shows

September 9th 2022

Rubraca improved progression-free survival in patients with BRCA1/2-mutant, platinum-sensitive, relapsed ovarian cancer, according to findings from the ARIEL4 clinical trial.

Phase 2 Trial to Study Novel Drug in Pretreated Solid Tumors

September 8th 2022

The first patient was treated in a phase 2 trial assessing the safety and efficacy of navicixizumab, with or without chemotherapy, in colorectal, gastric, ovarian and breast cancer.

I’m In a Great Place With My Cancer Despite Feeling 25 Years Older Than I Am

August 19th 2022

I am still here fighting, fighting hard and I will continue to do so to make sure I have more graduations, more weddings, and more everything that I can squeeze into my precious time left here on earth.